The Pharmacies and Drug Stores industry has exhibited growth despite some negative side effects from the regulatory environment. The industry has contended with PBMs not updating their payment benchmarks, thus causing the industry to not receive an adjusted reimbursement rate for their previous prescription sales, which has cut into industry revenue. Nevertheless, the patent cliff, which caused many blockbuster drugs to lose their patent exclusivity, has bolstered industry revenue due to the permeation of generic drugs in the market. In the next five years, industry revenue is forecast to grow, as healthcare reform will increase the number of individuals with health insurance.
Pharmacies and drug stores retail a range of prescription and over-the-counter medications, health and beauty items, toiletries and consumable goods directly to consumers on a walk-in basis. Industry companies may also provide basic health and photo processing services. The industry includes retail stores with a pharmacy but excludes mail-order retailers, hospitals and clinics.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.